These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6809110)

  • 41. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():50-6. PubMed ID: 10030433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug withdrawal after successful epilepsy surgery: how safe is it?
    Kerling F; Pauli E; Lorber B; Blümcke I; Buchfelder M; Stefan H
    Epilepsy Behav; 2009 Aug; 15(4):476-80. PubMed ID: 19546031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical guidelines for the management of epilepsy in adults with an intellectual disability.
    Working group of the International Association of the Scientific Study of Intellectual Disability
    Seizure; 2001 Sep; 10(6):401-9. PubMed ID: 11700992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European perspective of perampanel response in people with Intellectual Disability.
    Allard J; Henley W; Snoeijen-Schouwenaars F; van Ool J; Tan I; Jurgen Schelhaas H; Majoie MHJM; Hudson S; McLean B; Shankar R
    Acta Neurol Scand; 2020 Sep; 142(3):255-259. PubMed ID: 32383205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects.
    Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A
    Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discontinuing antiepileptic drugs.
    Pedley TA
    N Engl J Med; 1988 Apr; 318(15):982-4. PubMed ID: 3352688
    [No Abstract]   [Full Text] [Related]  

  • 48. A retrospective study on discontinuation of antiepileptic drugs following seizure remission.
    Kudo T; Amano K; Yagi K; Seino M
    Jpn J Psychiatry Neurol; 1994 Jun; 48(2):249-53. PubMed ID: 7807740
    [No Abstract]   [Full Text] [Related]  

  • 49. Behavioral and cognitive effects of lamotrigine.
    Meador KJ; Baker GA
    J Child Neurol; 1997 Nov; 12 Suppl 1():S44-7. PubMed ID: 9429130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The difficulties of diagnosing VPA-induced pancreatitis in children with severe motor and intellectual disabilities.
    Yoshikawa H
    Eur J Paediatr Neurol; 2004; 8(2):109-10. PubMed ID: 15253060
    [No Abstract]   [Full Text] [Related]  

  • 51. Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients.
    Chudnow RS; Dewey RB; Lawson CR
    Arch Neurol; 1997 Jul; 54(7):910-2. PubMed ID: 9236582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withdrawal of barbiturate anticonvulsant drugs: prospective controlled study.
    Coulter DL
    Am J Ment Retard; 1988 Nov; 93(3):320-7. PubMed ID: 3147687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin.
    Vossler DG
    Neurology; 1996 Mar; 46(3):852-3. PubMed ID: 8618710
    [No Abstract]   [Full Text] [Related]  

  • 54. Discontinuation of phenobarbital in children: effects on neurocognitive behavior.
    Riva D; Devoti M
    Pediatr Neurol; 1996 Jan; 14(1):36-40. PubMed ID: 8652013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognosis of epilepsy and withdrawal of treatment: withdrawal of treatment in childhood and adolescents].
    Herranz JL; Argumosa A
    Rev Neurol; 2000 Feb 16-29; 30(4):351-5. PubMed ID: 10789145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug withdrawal in patients with epilepsy: prognostic value of the EEG.
    Galimberti CA; Manni R; Parietti L; Marchioni E; Tartara A
    Seizure; 1993 Sep; 2(3):213-20. PubMed ID: 8162385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients' attitude toward AED withdrawal: A survey among individuals who had been seizure-free for over 2 years.
    Cvetkovska E; Babunovska M; Kuzmanovski I; Boskovski B; Sazdova-Burneska S; Aleksovski V; Isjanovska R
    Epilepsy Behav; 2020 Mar; 104(Pt A):106881. PubMed ID: 31931459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seizure recurrence and risk factors after withdrawal of chronic antiepileptic therapy in children.
    Caviedes BE; Herranz JL
    Seizure; 1998 Apr; 7(2):107-14. PubMed ID: 9627200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mysoline in the treatment of recalcitrant idiopathic major epilepsy in mentally defective children.
    COUSTON TA
    Arch Dis Child; 1954 Aug; 29(146):323-5. PubMed ID: 13189608
    [No Abstract]   [Full Text] [Related]  

  • 60. Beta-mannosidae deficiency in two mentally retarded girls with intractable seizures.
    Cherian MP
    Ann Saudi Med; 2004; 24(5):393-5. PubMed ID: 15573858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.